Multiple Ascending Dose Trial of BYK324677 in Healthy Volunteers
Status:
Completed
Trial end date:
2011-11-01
Target enrollment:
Participant gender:
Summary
This monocenter trial is conducted to obtain first data on safety, tolerability,
pharmacokinetics (PK) and pharmacodynamics (PD) after multiple ascending doses of BYK324677
in humans. In addition, the trial should provide preliminary information on a possible
influence of sex, food intake, and posology (once or twice daily administration of BYK324677)
to support the further planning of the drug development programme.